{"id":"W2800938049","doi":"10.1016/j.jid.2018.03.562","title":"554 The Janus kinase 1 (JAK1) inhibitor PF-04965842 reduces signs and symptoms of moderate to severe atopic dermatitis (AD)","year":2018,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Innovaderm (Canada); SKiN Health","funders":"","keywords":"Placebo; Eczema Area and Severity Index; SCORAD; Atopic dermatitis; Medicine; Internal medicine; Adverse effect; Gastroenterology; Randomized controlled trial; Placebo group; Severity of illness; Dermatology Life Quality Index; Dermatology; Pathology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001204531,0.0003238746,0.0004529143,0.0002681107,0.0002336454,0.0003592015,0.0002843696,0.0003380202,0.004712837],"category_scores_gemma":[0.0001762641,0.0001362433,0.0003113968,0.0001370093,0.000184943,0.000239005,0.0001964722,0.001073657,0.0008839555],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001468692,"about_ca_system_score_gemma":0.0002717849,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006755022,"about_ca_topic_score_gemma":0.001262104,"domain_scores_codex":[0.9998963,0.00001334511,0.000008842497,0.000009752084,0.00002705747,0.00004477257],"domain_scores_gemma":[0.9999312,0.00001048872,0.00001025131,0.00000541633,0.000005681556,0.00003687346],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.01754619,0.006699343,0.003016145,0.0005308583,0.0001717688,0.0005618483,0.00005612707,0.0006626774,0.8244807,0.0003194145,0.004433163,0.1415218],"study_design_scores_gemma":[0.01385766,0.08608685,0.2064856,0.0002806076,0.0006873615,0.004862586,0.0004637175,0.006523476,0.6455096,0.001131285,0.03402049,0.00009078823],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9861071,0.005432813,0.0004230982,0.0003667551,0.0002112337,0.0000751511,0.0003457849,0.0002860274,0.006752038],"genre_scores_gemma":[0.9936253,0.001774342,0.000511662,0.0001628705,0.00005824071,0.00002455176,0.0004072785,0.00001272515,0.003423052],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004712837,"threshold_uncertainty_score":0.01576602,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01941428179415063,"score_gpt":0.2734194561470067,"score_spread":0.2540051743528561,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}